Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R. Klein, Heather J. Symons, Nicolás J. Llosa et al.|Biology of Blood and Marrow Transplantation|2016Cited by 76
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R. Klein, Heather J. Symons, Elias T. Zambidis et al.|Biology of Blood and Marrow Transplantation|2016Cited by 73
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adultsHeather J. Symons, Ephraim J. Fuchs, Elias T. Zambidis et al.|Blood Advances|2020Cited by 73
Donor T cell DNMT3a regulates alloreactivity in mouse models of hematopoietic stem cell transplantationYiouli P. Ktena, Kenneth R. Cooke, Han-Hsuan Fu et al.|Journal of Clinical Investigation|2022Cited by 15